AIDS vaccine development. 1998

M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale

UI MeSH Term Description Entries
D009316 National Institutes of Health (U.S.) An operating division of the US Department of Health and Human Services. It is concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research. United States National Institutes of Health,National Institutes of Health
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015699 HIV Envelope Protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Envelope Glycoprotein gp120, HIV,HTLV-III gp120,env Protein gp120, HIV,gp120(HIV),HIV Envelope Glycoprotein gp120,gp120 Envelope Glycoprotein, HIV,HTLV III gp120,gp120, HTLV-III
D016915 AIDS Vaccines Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced. AIDS Vaccine,HIV Vaccine,HIV Vaccines,Vaccine, AIDS,Vaccine, HIV

Related Publications

M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
May 1998, Science (New York, N.Y.),
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
December 1995, International archives of allergy and immunology,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
March 1999, The Body positive,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
October 1998, AIDS research and human retroviruses,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
May 1999, AIDS patient care and STDs,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
December 2009, Uirusu,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
April 2005, The Indian journal of medical research,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
January 1988, AIDS & public policy journal,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
December 2013, European journal of immunology,
M Agosto, and J Allan, and C Benson, and E A Berger, and R Blumenthal, and D Burton, and J Clements, and J Coffin, and R Connor, and B Cullen, and R Desrosiers, and D Dimitrov, and R Doms, and M Emerman, and M Feinberg, and P Fultz, and C Gerard, and G Gonsalves, and A Haase, and N Haigwood, and V Hirsch, and D Ho, and J A Hoxie, and S L Hu, and D Zingale
January 1997, AIDS (London, England),
Copied contents to your clipboard!